AGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Argenica Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.16 AUD Market Closed

Market Cap: AU$20.6m

	Argenica Therapeutics Ltd ASX:AGN	AU
A	Allegheny Technologies Inc F:ATD	US
	SAP SE XETRA:SAP	DE
R	Reddit Inc NYSE:RDDT	US

Profitability Summary

Argenica Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-3 911%

Negative 3Y Average Operating Margin

-3 892%

Operating Margin is Increasing

-10 651% > -3 911%

Negative Net Margin

-2 946%

Negative 3Y Average Net Margin

-2 707%

Net Margin is Increasing

-7 893% > -2 946%

Negative Free Cash Flow Margin

-1 304%

Negative 3Y Average Free Cash Flow Margin

-1 334%

Free Cash Flow Margin is Increasing

-3 793% > -1 304%

Negative ROE

-118%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

735%

ROIC is Increasing

859% > 1 175%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.